Corcept Therapeutics(CORT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CORT Corcept Therapeutics

Trading 01-14 11:25:05 EST

37.12

+0.77

+2.12%

High37.12	Low35.71	Vol316.11K
Open36.10	D1 Closing36.35	Amplitude3.88%
Mkt Cap3.90B	Tradable Cap3.22B	Total Shares105.19M
T/O11.52M	T/O Rate0.36%	Tradable Shares86.88M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CORT","market":"US","secType":"STK","nameCN":"Corcept Therapeutics","latestPrice":37.12,"timestamp":1768407900549,"preClose":36.35,"halted":0,"volume":316109,"delay":0,"floatShares":86875270,"shares":105188217,"eps":0.873455,"marketStatus":"Trading","change":0.77,"latestTime":"01-14 11:25:05 EST","open":36.1,"high":37.12,"low":35.71,"amount":11515077.983494999,"amplitude":0.03879,"askPrice":37.13,"askSize":2,"bidPrice":37.1,"bidSize":492,"shortable":3,"etf":0,"ttmEps":0.873455,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1768424400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1081915200000,"exchange":"NASDAQ","adjPreClose":36.35,"preHourTrading":{"tag":"盘前","latestPrice":36.1,"preClose":36.35,"latestTime":"09:28 EST","volume":2849,"amount":103184.59767,"timestamp":1768400880083},"postHourTrading":{"tag":"盘后","latestPrice":36.5,"preClose":36.35,"latestTime":"19:57 EST","volume":31907,"amount":1160111.5635,"timestamp":1768352262333},"volumeRatio":0.673153,"impliedVol":0.7106,"impliedVolPercentile":0.5657},"requestUrl":"/m/hq/s/CORT/wiki","defaultTab":"wiki","newsList":[{"id":"2603575794","title":"A Look At Corcept Therapeutics (CORT) Valuation After The FDA Complete Response Letter On Relacorilant","url":"https://stock-news.laohu8.com/highlight/detail?id=2603575794","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603575794?lang=en_us&edition=fundamental","pubTime":"2026-01-13 07:22","pubTimestamp":1768260122,"startTime":"0","endTime":"0","summary":"What triggered the latest move in Corcept Therapeutics (CORT)?\nThe recent swing in Corcept Therapeutics (CORT) shares traces back to an FDA Complete Response Letter on relacorilant for hypertension secondary to hypercortisolism, which flagged the need for more effectiveness evidence despite pivotal trial endpoints being met.\nSee our latest analysis for Corcept Therapeutics.\nAfter the FDA setback, Corcept Therapeutics’ 1 day share price return of 2.66% and 7 day return of 7.30% have only...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/a-look-at-corcept-therapeutics-cort-valuation-after-the-fda","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/a-look-at-corcept-therapeutics-cort-valuation-after-the-fda","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CORT","BK4532","LU0566484027.USD","BK4007","LU1559883803.SGD"],"gpt_icon":0},{"id":"2602296320","title":"Top Growth Companies With Insider Ownership In January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602296320","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602296320?lang=en_us&edition=fundamental","pubTime":"2026-01-09 19:06","pubTimestamp":1767956761,"startTime":"0","endTime":"0","summary":"As of early 2026, the U.S. stock market is experiencing mixed movements, with the Dow Jones Industrial Average seeing gains while the Nasdaq has faced pressure from underperforming data-storage shares. Amidst this backdrop of fluctuating indices and sector-specific challenges, growth companies with high insider ownership often attract attention for their potential resilience and alignment between management and shareholder interests.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nyse-estc/elastic/news/top-growth-companies-with-insider-ownership-in-january-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nyse-estc/elastic/news/top-growth-companies-with-insider-ownership-in-january-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4608","LU1559883803.SGD","PROP","IE0009354923.USD","BK4613","SES","BK4096","BK4023","LU0082616367.USD","BK4007","BK4091","LU0274383776.USD","NIU","LU0054578231.USD","BK4543","LU2098885051.SGD","ESTC","BK4170","BK4603","LU0566484027.USD","BK7142","LU1861217088.USD","BK4588","BK4600","PGY","LU2290526834.HKD","BK4009","LU2125909916.SGD","BK4192","BK4595","BK4558","LU2089985449.USD","BK4532","LU2360107168.USD","LU2125909759.SGD","BK4585","LU1303367103.USD","TNMG","BK4213","BTDR","LU2931357623.SGD","LU1923622291.USD","LU1861215975.USD","BK4555","CORT","STUB","BK4141","LU1861220207.SGD","LU1861220033.SGD","BK4108","LU0053671581.USD","LU0719512351.SGD","LU2360107671.USD"],"gpt_icon":1},{"id":"2602317165","title":"Chief Development Officer William Guyer Reports Disposal of Corcept Therapeutics Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2602317165","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602317165?lang=en_us&edition=fundamental","pubTime":"2026-01-09 09:36","pubTimestamp":1767922590,"startTime":"0","endTime":"0","summary":"William Guyer, Chief Development Officer of Corcept Therapeutics Incorporated, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corcept Therapeutics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL49bNh9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Chief Development Officer William Guyer Reports Disposal of Corcept Therapeutics Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1559883803.SGD","BK4532","CORT","LU0566484027.USD","BK4007"],"gpt_icon":0},{"id":"2601833200","title":"Crinetics Experimental Pill Slashes Hormones In Rare Adrenal Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2601833200","media":"Benzinga_recent_news","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601833200?lang=en_us&edition=fundamental","pubTime":"2026-01-06 00:00","pubTimestamp":1767628800,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals reported positive topline results from Phase 2 studies of atumelnant for CAH and ACTH-dependent Cushing's syndrome.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/05/Medical-Research-And-Development-Center-_0.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/05/Medical-Research-And-Development-Center-_0.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/01/49697214/crinetics-experimental-pill-slashes-hormones-in-rare-adrenal-disease-trial","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/01/49697214/crinetics-experimental-pill-slashes-hormones-in-rare-adrenal-disease-trial","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0792757196.USD","LU0109394709.USD","BK4007","LU0154245756.USD","LU0823416689.USD","LU0162691827.USD","LU2324357040.USD","LU0889565916.HKD","BK4175","LU0310799852.SGD","LU0052756011.USD","LU0211327993.USD","LU1267930490.SGD","LU2065171402.SGD","BK4139","LU0889566641.SGD","LU1267930227.SGD","LU0128525689.USD","LU1571399168.USD","LU1880398554.USD","LU0566484027.USD","LU1880398471.USD","BK4532","LU0072461881.USD","LU2065170008.USD","CRNX","LU0320765992.SGD","NBIX","LU0310800965.SGD","SG9999001440.SGD","LU2065171311.SGD","LU0211328371.USD","LU1559883803.SGD","LU0006061336.USD","LU0154245673.USD","LU2065169927.USD","LU1267930813.SGD","BK4588","BK4585","CAH","CORT","LU0154236417.USD"],"gpt_icon":0},{"id":"2600173016","title":"Benzinga Bulls And Bears: Nike, SpaceX, Ultragenyx — And Chinese Tech Stocks Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2600173016","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600173016?lang=en_us&edition=fundamental","pubTime":"2026-01-03 22:01","pubTimestamp":1767448860,"startTime":"0","endTime":"0","summary":"Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/03/Bulls-and-Bears-1.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/03/Bulls-and-Bears-1.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/market-summary/26/01/49680245/benzinga-bulls-and-bears-nike-spacex-ultragenyx-and-chinese-tech-stocks-slide","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/26/01/49680245/benzinga-bulls-and-bears-nike-spacex-ultragenyx-and-chinese-tech-stocks-slide","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0633140560.USD","LU0786609619.USD","LU1934455277.USD","LU1066051225.USD","BK4220","LU0708995583.HKD","LU2756315318.SGD","QLD","LU1983260115.SGD","BK4503","LU2077746001.SGD","SG9999014559.SGD","BK4007","LU1316542783.SGD","LU0979878070.USD","LU2471134796.USD","SG9999015952.SGD","LU0251143458.SGD","LU2168564495.EUR","SG9999014914.USD","BK4534","IE00BJJMRX11.SGD","MACW.SI","BK4146","LU2125154935.USD","LU0154236417.USD","LU0868494708.USD","LU0823426480.USD","LU0117841782.USD","LU1868838027.USD","LU1935042991.SGD","LU2458330169.SGD","LU0918141705.HKD","LU2211815571.USD","LU0683595622.HKD","IE00BN29S564.USD","LU0345770308.USD","LU2272731782.SGD","IE00BQXX3C00.GBP","LU1235294995.USD","LU1951198990.SGD","LU0502904849.HKD","LU1582986433.USD","LU0187121727.USD","LU1674673428.USD","LU1934455194.USD","LU1232071149.USD","LU0724617625.USD","LU0308772762.SGD","LU2089284900.SGD","LU1956131251.USD","LU2125154778.USD","LU1691799644.USD","LU0516423091.SGD","QID","LU1989772923.USD","LU0444973449.USD","LU0472753341.HKD","LU1323998911.USD","LU0158827781.USD","LU0210528500.USD","IE00B19Z3581.USD","LU1868837136.USD","LU0198837287.USD","IE000W1ABFV2.USD","LU1066053197.SGD","LU0081259029.USD","LU0683600562.USD","LU1951200564.SGD","LU2106854487.HKD","IE00BGV7N243.SGD","IE00BYQQ9H92.USD","LU0345768153.USD","BK4516","LU1821325948.USD","LU2237957811.SGD","SG9999002224.SGD","LU0072462426.USD","LU0210526637.USD","SG9999002463.SGD","LU0868494617.USD","IE00BKDWB100.SGD","LU2039709279.SGD","LU0494093205.USD","LU1814569148.SGD","BK4502","LU1914381329.SGD","LU2237957902.USD","LU1152091168.USD","LU1127390331.HKD","LU0348814723.USD","LU1559883803.SGD","LU0067412154.USD","BK4548","IE00BJTD4N35.SGD","LU0553294199.USD","LU1732800096.USD","BK4559","LU0880133367.SGD","BK4505","LU0140636845.USD","SG9999014880.SGD","MREO","LU1868836914.USD","SG9999002232.USD","LU0265550359.USD","LU1629891620.HKD","LU1923622291.USD","LU1935043536.SGD","LU1699723380.USD","LU0056508442.USD","BK4576","LU2087589342.USD","LU0501845795.SGD","LU0456846285.SGD","LU0235996351.USD","LU1868836757.USD","LU2473716301.USD","LU2602419157.SGD","GB00BDT5M118.USD","LU0957791311.USD","LU0348723411.USD","LU0878005551.USD","LU1242518857.USD","LU2028103732.USD","IE00BHPRN162.USD","IE00BLSP4239.USD","3NVD.UK","LU0096364046.USD","LU0203201768.USD","LU2168563687.JPY","IE0004091025.USD","IE00B3M56506.USD","BK4512","IE00B5949003.HKD","LU1923623000.USD","BK4607","BK4524","LU2098885051.SGD","LU2347655073.USD","LU0072913022.USD","SG9999000418.SGD","LU0784385170.HKD","LU0061474705.USD","LU0310799852.SGD","LU2361045086.USD","LU2471134879.HKD","LU2237443465.HKD","LU0359202008.SGD","LU1051768304.USD","LU1105468828.SGD","LU1778281490.HKD","LU1551013425.SGD","LU0234570918.USD","LU2048586759.USD","LU2347655156.SGD","LU1051769294.HKD","LU2326559502.SGD","NVDD","SG9999014567.USD","LU0821914370.USD","LU1435385759.SGD","LU2250418816.HKD","LU2360107168.USD","BK4561","LU1868837565.USD","BK4511","LU0149725797.USD","LU0651946864.USD","LU0354030511.USD","LU2543165471.USD","IE00BK4W5M84.HKD","LU1769817096.USD","BK4509","SGXZ51526630.SGD","IE00B19Z8X17.USD","HK0000306701.USD","LU0516423174.USD","LU1291159041.SGD","LU2226246903.HKD","LU0820562030.AUD","LU0052750758.USD","IE00BBT3K403.USD","LU0463099449.HKD","IE00B29SXG58.USD","LU0689626769.HKD","SQQQ","ALBmain","LU0158827948.USD","LU1791710582.SGD","LU0823414551.USD","LU0561508036.HKD","NVDY","LU0106959298.USD","TQQQ","LU2750360641.GBP","IE00B19Z3B42.SGD","LU1880383366.USD","LU0797268264.HKD","LU0048584097.USD","IE0034235188.USD","LU2087625088.SGD","LU0557290698.USD","BK4531","LU0516422366.SGD","LU1551013342.USD","BK4535","LU2065169927.USD","NVD","LU0316494557.USD","LU0310800379.SGD","LU2213496289.HKD","LU0353189763.USD","IE00BFSS7M15.SGD","LU0417517546.SGD","IE0004086264.USD","LU0650527681.SGD","LU0823434740.USD","BK4538","LU0531971595.HKD","LU0157215616.USD","IE00B775SV38.USD","LU0006306889.USD","LU0175139822.USD","LU1719994722.HKD","SGXZ31699556.SGD","LU0444971666.USD","LU0823414478.USD","LU1303224171.USD","LU2257852520.SGD","LU0912757837.SGD","LU1974910355.USD","LU0109392836.USD","LU0889565833.HKD","LU1633808545.USD","LU2087621335.USD","LU1791710400.SGD","LU2237443549.SGD","LU2023251221.USD","LU0348805143.USD","LU0203345920.USD","LU1861127337.USD","LU1003077747.HKD","LU0345769631.USD","BK4526","LU2286300806.USD","LU1989771016.USD","LU1145028129.USD","LU2430703251.USD","LU0823421333.USD","LU2461242641.AUD","LU2265009873.SGD","LU0661504455.SGD","LU2125909759.SGD","LU2290526834.HKD","LU1989764664.SGD","LU2092627202.USD","NQmain","LU0787776722.HKD","IE00BQXX3F31.USD","LU0820561818.USD","LU0708994859.HKD","LU1066051811.HKD","LU0726765562.USD","LU1861558580.USD","LU0359201885.HKD","IE0034235295.USD","LU0784383803.USD","IE00BDRTCR15.USD","SG9999014906.USD","LU1992135472.HKD","LU2168564149.EUR","LU0289960550.SGD","LU1244550577.SGD","BK4565","LU0348827113.USD","LU2413666699.HKD","LU1069344957.HKD","LU2168564065.EUR","LU1868837722.USD","LU0077335932.USD","SG9999002828.SGD","LU0256863902.USD","LU0823413587.USD","LU1037948541.HKD","LU2463028550.USD","LU0328353924.USD","LU0784384876.USD","LU1119994496.HKD","LU0823397285.USD","BK4532","LU1048596156.SGD","LU0605514214.HKD","LU0949170772.SGD","BK4608","LU2023250330.USD","NVDU","LU1923622614.USD","LU2452424414.USD","LU0965509010.AUD","IE00BKPKM429.USD","LU2433249047.HKD","LU2491050071.SGD","IE00BJTD4V19.USD","IE0034235303.USD","LU0390134368.USD","LU1720050803.USD","LU0689472784.USD","LU1868837300.USD","LU0345770993.USD","LU2065171311.SGD","IE0005OL40V9.USD","LU2860962120.EUR","IE00B1XK9C88.USD","LU0320765059.SGD","LU0823038988.USD","LU0348816934.USD","BK4533","SG9999015986.USD","IE00BKVL7J92.USD","LU1280957306.USD","LU2552382132.HKD","LU2237443382.USD","LU1116320901.HKD","LU0327786744.USD","BK4122","USAW.SI","SG9999018865.SGD","BK4554","IE00BDCRKT87.USD","LU2264538146.SGD","LU2097344431.USD","IE00B19Z8W00.USD","MNQmain","SG9999014674.SGD","BK4501","LU0342679015.USD","CORT","LU0784385840.USD","LU1267930490.SGD","SGXZ23171101.USD","LU0633140727.USD","IE00B1BXHZ80.USD","LU0353189680.USD","IE0008368742.USD","LU0072462343.USD","LU0348788117.USD","LU1548497426.USD","LU1868836591.USD","LU1506573853.SGD","LU0964807845.USD","LU1261432733.SGD","LU1718418525.SGD","IE0004445239.USD","LU1961090484.USD","BK4575","LU0082616367.USD","LU2023250843.SGD","LU0823434583.USD","BK4566","BK4587","LU1303367103.USD","LU2083900584.USD","LU1251922891.USD","LU0289739343.SGD","BK4507","LU0820561909.HKD","LU1244550221.USD","SGXZ81514606.USD","LU2931357623.SGD","LU0354030438.USD","LU0942090050.USD","IE00B19Z9505.USD","LU2381873111.SGD","IE00BZ199S13.USD","LU0251132253.USD","IE0002270589.USD","LU0323591593.USD","LU1116320737.USD","LU1235295612.USD","LU0516422440.USD","LU1066051498.USD","LU0466842654.USD","LU1035775433.USD","LU0211328371.USD","SNVD.UK","LU1815336760.USD","LU0566484027.USD","IE00BZ1G4Q59.USD","LU1981816686.USD","LU0594300419.USD","LU0320764599.SGD","LU0256863811.USD","LU2360106780.USD","IE00BLSP4452.SGD","LU0456827905.SGD","IE0001KFT4U8.USD","LU1861215975.USD","LU1571399168.USD","LU1674673691.USD","LU2361044949.HKD","IE00BK4W5L77.USD","BK4550","LU1267930573.SGD","LU2065171402.SGD","LU0094547139.USD","LU0329678337.USD","LU2357305700.SGD","IE00B4YYXB79.USD","LU0029864427.USD","LU2360032135.SGD","LU1823568750.SGD","LU0225283273.USD","NVDS","LU2211817866.USD","LU2054465674.USD","IE00B3SWFQ91.USD","LU2065170008.USD","IE00B7KXQ091.USD","NVIW.SI","HK0000320264.USD","LU0642271901.SGD","LU0795875086.SGD","LU2177674079.SGD","LU0259732245.USD","LU2491050154.USD","LU0310800965.SGD","LU2552382215.SGD","LU2505996509.AUD","LU2417539215.USD","BK4543","IE00BMPRXN33.USD","LU1934455863.HKD","LU1917777945.USD","LU0788109477.HKD","SG9999015341.SGD","USJW.SI","LU1037948897.HKD","LU2430703095.HKD","NVD3.UK","LU2023250504.SGD","LU2168564222.USD","LU2272731600.USD","IE0009356076.USD","BK4567","LU0640476718.USD","LU1688375341.USD","LU2456880835.USD","LU0265550946.USD","IE0034224299.USD","LU0965509283.SGD","LU1839511570.USD","BK4571","SG9999014542.SGD","LU1861220033.SGD","LU2756315664.SGD","LU1770034418.SGD","BK4585","LU2133065610.SGD","IE00B4JS1V06.HKD","LU0823426308.USD","LU2506951792.HKD","LU2592432038.USD","IE0004445015.USD","LU2271345857.HKD","BK4581","LU1582987597.SGD","LU0672654240.SGD","LU0792757196.USD","LU1721428933.USD","LU0057025933.USD","LU1282648689.USD","LU0708995401.HKD","LU1732799900.SGD","LU0315179316.USD","LU2458330243.SGD","LU2242649171.HKD","LU1808992512.USD","IE0003U64NQ7.SGD","LU1769817179.HKD",".IXIC","LU2097344357.USD","BK4588","LU0143863784.USD","LU2249611893.SGD","BK4529","LU1023057109.AUD","NVDX","LU2746668461.USD","LU1803068979.SGD","LU0359201612.USD","SG9999002562.SGD","LU2092937148.SGD","LU2399975544.HKD","BK4139","LU1989772840.SGD","IE00BWXC8680.SGD","LU0823413660.USD","LU2148611432.USD","LU1935043023.USD","LU0949170426.SGD","LU1267930227.SGD","LU0203347892.USD","LU0039217434.USD","LU1244550494.USD","LU2361044865.SGD","IE00BJLML261.HKD","IE00B775H168.HKD","LU0719512351.SGD","LU1935042488.USD","LU0053666078.USD","LU0545039389.USD","LU2750360997.AUD","LU0244354667.USD","LU1496350502.SGD","LU0528227936.USD","LU2111349929.HKD","LU0455707207.USD","IE00B0JY6N72.USD","LU2063271972.USD","LU2125909247.SGD","LU2487616109.SGD","LU0511384066.AUD","LU1861559042.SGD","LU0011850046.USD","LU1008478684.HKD","HK0000320223.HKD","LU0052756011.USD","BK4604","LU1301847155.USD","LU0329678170.USD","LU2244417387.USD","LU0651947912.USD","LU2413666426.HKD","LU0965509101.SGD","LU0516422952.EUR","LU2430703178.SGD","LU2237443895.HKD","LU1582987324.SGD","LU2089283258.USD","IE00BFXG0V08.USD","BK4555","LU0051755006.USD","LU1048588211.SGD","IE000ITXATA3.USD","IE00BMPRXR70.SGD","IE00BJJMRY28.SGD","NVDS.UK","BK4527","BK4553","LU0234572021.USD","UFO","SG9999015358.SGD","LU1880383440.USD","LU1794554557.SGD","LU0238689110.USD","IE00BQXX3D17.EUR","LU0588546209.SGD","BK4551","LU0572944931.SGD","LU0210536198.USD","LU0918141887.USD","SG9999014898.SGD","LU2247934214.USD","LU2125909593.SGD","LU0170899867.USD","SG9999015945.SGD","LU1989764748.USD","LU1429558221.USD","LU1852331112.SGD","BK4598","LU1623119135.USD","LU2896262040.SGD","PSQ","IE000YTNTUN2.SGD","LU0276348264.USD","LU1152091754.HKD","NKE","IE00B3S45H60.SGD","LU0079474960.USD","LU1992135399.USD","LU0109391861.USD","LU0985320562.USD","SG9999004303.SGD","LU1267930813.SGD","LU2471134523.USD","IE00BN8TJ469.HKD","IE00BSNM7G36.USD","LU2125909916.SGD","LU0128525689.USD","LU0127658192.USD","LU0957808578.USD","LU0370786039.SGD","LU1582986359.USD","LU1720051108.HKD","LU0314104364.USD","IE00BD6J9T35.USD","LU0738911758.USD","LU1046422090.SGD","BK4558","LU0589944569.HKD","LU0345768740.USD","LU0348825331.USD","LU0070217475.USD","BK4170","LU0347712357.USD","LU0823421416.USD","LU0871576103.HKD","LU1171460220.USD","LU0061474960.USD","LU0476273544.USD","LU0106261372.USD","LU0314106906.USD","LU1515016050.SGD","LU0215105999.USD","LU1712237335.SGD","LU1206713676.USD","LU2322448791.USD","LU2191332357.HKD","IE00BFSS8Q28.SGD","LU1815333072.USD","LU2272731865.HKD","LU1323610961.USD","LU0737861772.HKD","LU1267930730.SGD","LU2236285917.USD","LU2491049909.HKD","LU0417516902.SGD","LU0143863198.USD","LU0210533765.USD","SG9999001424.SGD","LU1496350171.SGD","SGXZ99366536.SGD","LU0128525929.USD","LU0345769128.USD","LU1064131342.USD","LU2505996681.GBP","LU0080751232.USD","IE00B7SZLL34.SGD","LU0943347566.SGD","LU0795875169.SGD","LU1642822529.SGD","LU2746668974.SGD","SG9999014575.USD","LU2108987350.USD","LU0069063385.USD","LU1366333091.USD","NVD2.UK","IE00BMPRXQ63.HKD","2NVD.UK","LU0267386448.USD","BK4614","LU0124676726.USD","LU0231483743.USD","IE00BYXW3230.USD","LU0594300179.USD","BK4549","LU2242644610.SGD","LU0097036916.USD","BK4504","LU0266013472.USD","LU0047713382.USD","LU1720051017.SGD","LU2237438978.USD","LU2008162690.USD","SG9999018857.SGD","LU2357125470.USD","SG9999017495.SGD","LU2322448957.HKD","LU1188198961.HKD","LU0164865239.USD","LU1935042215.USD","HK0000306685.HKD","LU1084165304.USD","LU0048580855.USD","IE000KEQY171.SGD","BK4592","BK4579","LU2089985449.USD","LU0889566641.SGD","LU0289961442.SGD","LU0307460666.USD","LU1206712785.SGD","LU2552382058.USD","SG9999015978.USD","LU2242650005.HKD","BK4573","LU0823411888.USD","IE0009G5SDU7.USD","LU0965508806.USD","BK4099","LU0096362180.USD","BK4612","BK4574","LU0456855351.SGD","LU2471134952.CNY","LU0049112450.USD","LU1242518931.SGD","LU2462157665.USD","BK4605","LU0882574139.USD","LU0107464264.USD","LU0823397103.USD","TSYW.SI","LU1988902786.USD","LU0061475181.USD","LU0861579265.USD","LU2237443622.USD","LU0823039010.USD","IE00BFMHRM44.USD","LU1046421795.USD","LU2294711713.HKD","BK4141","LU1366192091.USD","LU2237443978.SGD","LU2403377893.USD","LU1804176565.USD","IE00BF5LJ272.USD","LU0211327993.USD","LU0274383776.USD","LU0203202063.USD","LU2420271590.USD","RARE","LU0326950275.SGD","BK4515"],"gpt_icon":1},{"id":"2600509320","title":"Insider Picks For High Growth In January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2600509320","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600509320?lang=en_us&edition=fundamental","pubTime":"2026-01-03 01:05","pubTimestamp":1767373532,"startTime":"0","endTime":"0","summary":"As the U.S. markets kick off 2026 with a mixed start following a four-session skid to close out 2025, investors are keenly observing the broader economic landscape shaped by recent advances in AI and fluctuating interest rates. In such an environment, companies with high insider ownership can signal confidence from those who know the business best, making them appealing choices for growth-focused portfolios amidst these market conditions.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nasdaq-api/agora/news/insider-picks-for-high-growth-in-january-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nasdaq-api/agora/news/insider-picks-for-high-growth-in-january-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["API","LU0231459107.USD","BK4147","BK4503","ALMU","BK4543","BK4588","LU0274383776.USD","LU1861220033.SGD","LU0594300179.USD","LU0650527681.SGD","LU2290526834.HKD","BK4170","BK4096","EH","CORT","ALAB","BK4108","BK4555","LU0605514214.HKD","BK4023","LU0082616367.USD","BK4142","SES","BK4213","BK4091","STUB","BK4532","BTDR","BK4141","LU2089985449.USD","NIU","BK4600","IE0009354923.USD","LU2360107168.USD","BK4595","ATAT","SMCI","LU0566484027.USD","BK7103","LU2460026573.USD","BK4535","BK4007","LU1559883803.SGD","LU0719512351.SGD","LU1861215975.USD","LU2931357623.SGD","BK4551","BK4558","LU0053671581.USD","LU0594300419.USD","BK4585","BK4187","BK4192","CRDO","PROP","BK4603"],"gpt_icon":1},{"id":"2600105071","title":"Corcept Therapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2600105071","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600105071?lang=en_us&edition=fundamental","pubTime":"2026-01-02 19:14","pubTimestamp":1767352440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CORT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 02, 2026 06:14 ET (11:14 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT"],"gpt_icon":0},{"id":"2600065364","title":"January 2026's Leading Growth Companies With Insider Influence","url":"https://stock-news.laohu8.com/highlight/detail?id=2600065364","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600065364?lang=en_us&edition=fundamental","pubTime":"2026-01-02 19:05","pubTimestamp":1767351925,"startTime":"0","endTime":"0","summary":"As 2025 concludes, the U.S. stock market has shown impressive resilience with major indexes like the Nasdaq, S&P 500, and Dow Jones Industrial Average posting substantial gains despite a challenging final trading week. In this environment of robust growth and evolving economic policies, companies with high insider ownership can offer unique insights into their potential for success, as insiders often have a deeper understanding of their company's prospects and challenges.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/8032000-choice1-main-header/1585186551780","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8032000-choice1-main-header/1585186551780"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/diversified-financials/nyse-pay/paymentus-holdings/news/january-2026s-leading-growth-companies-with-insider-influenc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/diversified-financials/nyse-pay/paymentus-holdings/news/january-2026s-leading-growth-companies-with-insider-influenc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0605514214.HKD","CRDO","LU0650527681.SGD","BK4227","BK4595","BK4091","BK4558","ALAB","BK4007","NIU","BK4142","LU0231459107.USD","BK4170","BK7111","LU1861215975.USD","SES","LU0566484027.USD","LU2931357623.SGD","BK4585","BK4192","BTDR","LU1559883803.SGD","BK4213","BK4539","LU2089985449.USD","BK4023","BK4588","PAY","BK4096","BK4555","LU0053671581.USD","LU0274383776.USD","BK4108","LU0594300419.USD","BK4141","CORT","BK4543","ATAT","LU0082616367.USD","IE0009354923.USD","BK4106","BK4532","LU2290526834.HKD","MAX","LU2460026573.USD","LU0719512351.SGD","PROP","LU0594300179.USD","LU1861220033.SGD","LU2360107168.USD","BK4603","STUB","BK4077","BK4600"],"gpt_icon":1},{"id":"2600059646","title":"U.S. RESEARCH ROUNDUP-Axsome Therapeutics, Block, Terawulf","url":"https://stock-news.laohu8.com/highlight/detail?id=2600059646","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600059646?lang=en_us&edition=fundamental","pubTime":"2026-01-02 14:49","pubTimestamp":1767336556,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Axsome Therapeutics, Block, TerawulfJan 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Axsome T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260102:nL4N3Y3073:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4223","LU0719512351.SGD","LU1366333091.USD","BK4532","LU1868836591.USD","IE00B19Z3581.USD","LU0889566641.SGD","LU1548497426.USD","CMG","HWM","DBRG","BK4023","IE00B7SZLL34.SGD","LU0203345920.USD","HPP","CORT","BILL","LU1791807156.HKD","SYF","BK4141","LU1074936037.SGD","LU1267930730.SGD","WULF","LU1861559042.SGD","LU1720051108.HKD","ARWR","BK4504","MGM","XYZ","COF","LU2360106780.USD","FOUR","IE00BFMHRM44.USD","ULTA","LU0683600562.USD","LU0477156797.USD","MU","LU2125909759.SGD","LU0056508442.USD","CWBC","BK4579","LU1267930813.SGD","SGXZ99366536.SGD","LU1201861249.SGD","LU0106831901.USD","BFH","LU0211331839.USD","AXSM","IE0009354923.USD","LU1868836914.USD"],"gpt_icon":1},{"id":"2600832087","title":"Top Growth Companies With High Insider Ownership In January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2600832087","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600832087?lang=en_us&edition=fundamental","pubTime":"2026-01-01 19:05","pubTimestamp":1767265524,"startTime":"0","endTime":"0","summary":"As the U.S. stock market wraps up 2025 with impressive double-digit gains despite a late-year dip, investors are increasingly focused on companies that not only demonstrate robust growth potential but also have significant insider ownership. In this environment, high insider ownership can be a positive indicator of confidence in a company's future prospects, aligning insiders' interests with those of shareholders and potentially offering added stability amidst market fluctuations.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/retail/nasdaq-ptrn/pattern-group/news/top-growth-companies-with-high-insider-ownership-in-january-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/retail/nasdaq-ptrn/pattern-group/news/top-growth-companies-with-high-insider-ownership-in-january-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NIU","PTRN","BK4220","LU2065171311.SGD","LU1559883803.SGD","BK4539","LU2065170008.USD","LU2931357623.SGD","BK4142","BK4192","BK4170","BK4007","IE0009354923.USD","BK4096","ATAT","SMCI","BK4588","BK4543","BK4213","BTDR","SES","LU0594300179.USD","ALAB","LU0231459107.USD","MNDY","LU0566484027.USD","BK4144","BK4613","BK4555","LU1720051017.SGD","PROP","STUB","CORT","LU0594300419.USD","LU2460026573.USD","BK4600","BK4558","LU2065169927.USD","BK4532","LU1548497426.USD","LU1861220033.SGD","LU0605514214.HKD","LU2360107168.USD","LU0719512351.SGD","BK4141","BK4585","CRDO","NFE","LU1720051108.HKD","LU1861215975.USD","BK4138","LU0082616367.USD","LU0053671581.USD","BK4108","LU0274383776.USD","LU2065171402.SGD","LU2290526834.HKD","BK4023","LU2357305700.SGD","LU0650527681.SGD","BK4603","BK4097","BK4091","BK4595","LU2089985449.USD"],"gpt_icon":1},{"id":"2600090927","title":"US Equity Markets Fall on Final Day of 2025 Amid Broad Market Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2600090927","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600090927?lang=en_us&edition=fundamental","pubTime":"2026-01-01 05:04","pubTimestamp":1767215065,"startTime":"0","endTime":"0","summary":"Major US equity indexes closed lower Wednesday amid a broad market decline, as the year came to an end, despite a better-than-expected jobless claims report.* Seasonally adjusted initial jobless claim","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":[".IXIC","MYMmain","BK4007","MNQmain","LU0029864427.USD","BK4588","LU0823411888.USD","BK4532","DJX","LU0708994859.HKD","LU0889566641.SGD","BK4566","BK4533","BK4215","BK4558","SDOW","CORT","LU1267930573.SGD","QID","BK4146","LU1559883803.SGD","EQR","SQQQ","LU0566484027.USD","TSYW.SI","LU0310800379.SGD","BK4561","TQQQ","USJW.SI",".DJI","DXD","LU2098885051.SGD","NVIW.SI","UDOW","BK4585",".SPX","DOG","NQmain","LU0786609619.USD","LU0128525929.USD","BK4581","LU0792757196.USD","PSQ","QLD","IE00BYQQ9H92.USD","DDM","LU1267930813.SGD","USAW.SI"],"gpt_icon":1},{"id":"2600705847","title":"Corcept Therapeutics Down Over 48%, on Pace for Largest Percent Decrease Since May 2014 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2600705847","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600705847?lang=en_us&edition=fundamental","pubTime":"2026-01-01 01:40","pubTimestamp":1767202800,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics Incorporated.  is currently at $36.14, down $34.06 or 48.52%. --Would be lowest close since Sept. 12, 2024, when it closed at $35.71. --On pace for largest percent decrease since May 7, 2014, when it fell 50.5%. --Currently down four consecutive days; down 56.77% over this period. --Longest losing streak since Nov. 18, 2025, when it fell for five straight trading days. --Down 54.49% month-to-date; on pace for worst month since Aug. 2006, when it fell 67.65%. --Down 68.36% from its all-time closing high of $114.22 on March 31, 2025. --Down 28.29% from 52 weeks ago , when it closed at $50.39. --Traded as low as $32.99; lowest intraday level since Aug. 5, 2024, when it hit $32.33. --Down 53% at today's intraday low; largest intraday percent decrease since Aug. 25, 2006, when it fell as much as 74.86%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1559883803.SGD","BK4532","BK4007","LU0566484027.USD","CORT"],"gpt_icon":0},{"id":"2595700437","title":"Wolfe Research Downgrades Corcept Therapeutics to Underperform from Peer Perform, Price Target is $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2595700437","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595700437?lang=en_us&edition=fundamental","pubTime":"2025-12-31 23:39","pubTimestamp":1767195590,"startTime":"0","endTime":"0","summary":"Price: 34.51, Change: -35.69, Percent Change: -50.84","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CORT"],"gpt_icon":0},{"id":"2595771796","title":"US FDA Declines to Approve Corcept's Drug for Rare Hormonal Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2595771796","media":"Reuters","labels":["policyRegulatory","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595771796?lang=en_us&edition=fundamental","pubTime":"2025-12-31 23:16","pubTimestamp":1767194196,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration has declined to approve Corcept Therapeutics' drug for the treatment of a rare hormonal disorder.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b9e90ab36df29de2b226d0a3b3c0d142","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nL4N3Y10I1:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"US FDA Declines to Approve Corcept's Drug for Rare Hormonal Disorder","news_tag":"policyRegulatory,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT","LU0566484027.USD","LU1559883803.SGD","BK4532","BK4007"],"gpt_icon":0},{"id":"1126069625","title":"Corcept Therapeutics (CORT.US) Plummets Over 46% Following FDA Rejection of New Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1126069625","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126069625?lang=en_us&edition=fundamental","pubTime":"2025-12-31 23:04","pubTimestamp":1767193471,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics (CORT.US) saw its stock price plunge more than 46% on Wednesday, closing at $37.33. The sharp decline came after the company announced it had received a Complete Response Letter...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b9e90ab36df29de2b226d0a3b3c0d142","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159891","BK4532","LU0566484027.USD","LU1559883803.SGD","CORT","BK4007"],"gpt_icon":0},{"id":"2595055777","title":"These Stocks Are Moving the Most Today: Nvidia, Tesla, Hecla, Newmont, Nike, Vanda, Corcept, DJT, and More -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2595055777","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595055777?lang=en_us&edition=fundamental","pubTime":"2025-12-31 22:48","pubTimestamp":1767192480,"startTime":"0","endTime":"0","summary":"Stocks fell modestly on the last trading day of the year for Wall Street.Nvidia rose 0.7%. The chip maker's stock has been hit by fears of competition from rival hardware but the prospect of resumed sales in China could point the way to future gains for the shares.Tesla rose slightly as investors in the electric-vehicle maker prepared for the release Friday of fourth-quarter delivery numbers, which are projected to decline.Hecla Mining -- the largest U.S. silver producer -- fell 1.5%. The price of the white metal dropped 8% after exchange operator CME Group increased margin requirements for the second time in a week.Vanda Pharmaceuticals jumped 34% after the Food and Drug Administration approved Nereus as a treatment to prevent vomiting induced by motion.Corcept Therapeutics sank 46%. The company said that while the Food and Drug Administration acknowledged the company's Grace trial for relacorilant met its primary endpoint and that data from Corcept's Gradient trial provided confirmat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3eb2d9009b0efa0aac8b016a084e0843","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2381873111.SGD","LU2023250330.USD","LU0266512127.USD","LU1815336760.USD","NVDS","LU1633808545.USD","BK4555","LU0724617625.USD","LU0654597011.USD","IE00B4JS1V06.HKD","LU1223082519.USD","LU2242650005.HKD","LU0070217475.USD","LU1720051017.SGD","HL","BK4527","LU2168563687.JPY","LU0788108826.HKD","LU0256863811.USD","IE0004445015.USD","2NVD.UK","LU0048584097.USD","LU0498741114.HKD","LU1935043023.USD","LU1718418525.SGD","LU2543165471.USD","LU1642822529.SGD","IE0034235188.USD","LU1435385759.SGD","IE000W1ABFV2.USD","LU1935043536.SGD","LU0109392836.USD","BK4077","IE0003U64NQ7.SGD","IE000YTNTUN2.SGD","LU0708995401.HKD","LU0957791311.USD","IE00B5949003.HKD","LU1935042488.USD","LU0786609619.USD","LU2471134523.USD","LU0347712357.USD","LU1883866441.USD","LU1223083913.SGD","LU0310800379.SGD","SG9999001424.SGD","LU2108987350.USD","LU0029864427.USD","BK4558","IE00BFXG0V08.USD","IE000ITXATA3.USD","LU1720051108.HKD","IE00BMPRXR70.SGD","LU0345780281.USD","LU1868836757.USD","SGXZ23171101.USD","LU0882574139.USD","LU0096364046.USD","IE00BK4W5M84.HKD","LU0006306889.USD","LU1623119135.USD","LU1691799644.USD","IE00B7KXQ091.USD","IE00B3SWFQ91.USD","LU2125909759.SGD","LU1280957306.USD","BK4614","IE00BSNM7G36.USD","LU1066053197.SGD","LU1861127337.USD","LU1861220033.SGD","LU2272731782.SGD","LU1267930730.SGD","LU1804176565.USD","LU2413666426.HKD","LU2092627202.USD","IE00BJTD4N35.SGD","LU0965509101.SGD","LU1127390331.HKD","LU2242649171.HKD","LU2360032135.SGD","BK4598","LU0081259029.USD","BK4581","LU0724618789.USD","IE00B19Z8W00.USD","LU2430703095.HKD","LU1323610961.USD","SG9999015986.USD","HK0000320264.USD","LU0444971666.USD","LU2125909247.SGD","LU0511384066.AUD","LU1934455194.USD","IE00BFSS7M15.SGD","LU1037948897.HKD","LU2168564222.USD","LU2602419157.SGD","LU1551013425.SGD","LU1066051811.HKD","BK4585","LU1791710582.SGD","IE00BN29S564.USD","LU0689472784.USD","LU1923622614.USD","BK4549","LU2750360641.GBP","LU0128525929.USD","LU2456880835.USD","LU0354030511.USD","BK4605","LU0689626769.HKD","BK4534","LU1839511570.USD","LU0187121727.USD","BK4612","LU1699723380.USD","IE00BKVL7J92.USD","LU0612318385.USD","LU0106261372.USD","LU1988902786.USD","SG9999014559.SGD","LU0979878070.USD","LU0708994859.HKD","LU1244550494.USD","LU1023059493.AUD","NVD3.UK","SG9999014880.SGD","LU0345780521.USD","LU0823421416.USD","LU0612318971.USD","LU0080751232.USD","NVDS.UK","3NVD.UK","LU0069063385.USD","LU1951198990.SGD","LU0203202063.USD","LU2092937148.SGD","BK4543","LU1868836591.USD","LU0787776722.HKD","LU1814569148.SGD","LU0320765059.SGD","LU0964807845.USD","IE00BKPKM429.USD","LU2592432038.USD","SG9999001143.SGD","LU1861558580.USD","LU2191332357.HKD","LU2272731600.USD","BK4570","SGXZ81514606.USD","LU2357125470.USD","LU1267930573.SGD","LU2089283258.USD","LU2473716301.USD","SG9999015358.SGD","IE00BQXX3D17.EUR","LU1803068979.SGD","LU2461242641.AUD","LU2552382215.SGD","IE0009356076.USD","LU1923622291.USD","LU2498475776.HKD","LU0823421333.USD","LU2087621335.USD","BK4550","LU1064131342.USD","LU2491050154.USD","LU0170899867.USD","LU0225283273.USD","BK4561","LU0097036916.USD","LU1551013342.USD","LU2458330169.SGD","LU2098885051.SGD","LU1119994496.HKD","LU1815333072.USD","LU2125154778.USD","IE00BWXC8680.SGD","LU2430703251.USD","IE0001KFT4U8.USD","LU2322448791.USD","NVD","IE0004086264.USD","IE00B4YYXB79.USD","LU0345780950.USD","LU2237438978.USD","LU1992135472.HKD","LU2247934214.USD","IE00BMPRXQ63.HKD","LU2931357623.SGD","LU2746668974.SGD","LU0211327993.USD","LU2860962120.EUR","LU2750360997.AUD","LU2326559502.SGD","LU0210528500.USD","LU2403377893.USD","IE00B19Z9505.USD","LU1868836914.USD","VNDA","LU0943347566.SGD","LU2487616109.SGD","LU2462157665.USD","LU0792757196.USD","IE0004091025.USD","LU2462611646.USD","LU0158827948.USD","LU0082616367.USD","LU2420271590.USD","LU0496367417.USD","LU2413666699.HKD","LU0265550359.USD","SG9999000418.SGD","LU1989764748.USD","LU2463028550.USD","SG9999014575.USD","LU0965508806.USD","IE00BJTD4V19.USD","LU1992135399.USD","LU2756315318.SGD","NVDU","LU2168564065.EUR","LU1548497426.USD","LU0820561909.HKD","LU0127658192.USD","IE000KEQY171.SGD","LU0308772762.SGD","LU0345770308.USD","LU0289960550.SGD","IE0009G5SDU7.USD","SG9999015978.USD","LU1821325948.USD","LU0965509283.SGD","LU2249611893.SGD","LU1934455277.USD","LU0053666078.USD","SG9999014542.SGD","LU0353189763.USD","LU1974910355.USD","LU1116320737.USD","LU2264538146.SGD","BK4017","LU1712237335.SGD","IE00B775H168.HKD","LU2125909916.SGD","LU2458330243.SGD","LU0444973449.USD","BK4566","NVIW.SI","LU0061475181.USD","SG9999004303.SGD","LU1868837136.USD","LU2452424414.USD","LU0300736062.USD","LU2087625088.SGD","BK4574","LU1989772840.SGD","LU2290526834.HKD","LU0342679015.USD","LU2250418816.HKD","LU1989772923.USD","LU0528227936.USD","LU0942090050.USD","LU1244550577.SGD","BK4547","IE00BK4W5L77.USD","LU0719512351.SGD","LU2211815571.USD","LU1571399168.USD","SG9999014914.USD","LU0354030438.USD","LU1069344957.HKD","LU0267386448.USD","LU2506951792.HKD","BK4141","LU0289739343.SGD","LU0210536198.USD","LU2360107168.USD","LU1366192091.USD","LU0472753341.HKD","LU2746668461.USD","LU0630314457.HKD","HK0000306685.HKD","BK4099","LU1778281490.HKD","LU0077335932.USD","LU0289961442.SGD","LU0368265764.SGD","LU0823411888.USD","LU1242518857.USD","LU2125154935.USD","LU2360106780.USD","NVDA","LU1223082196.USD","HK0000306701.USD","LU0109391861.USD","SG9999015341.SGD","LU0266013472.USD","LU1674673428.USD","LU2357305700.SGD","LU1430597077.USD","HK0000320223.HKD","SG9999002224.SGD","LU0823434740.USD","LU2125909593.SGD","LU0348723411.USD","LU0094547139.USD","LU0345769631.USD","LU1983260115.SGD","LU2106854487.HKD","BK4551","LU0057025933.USD","LU1917777945.USD","LU2505996681.GBP","LU1267930813.SGD","LU2756315664.SGD","LU0820561818.USD","LU0079474960.USD","LU2896262040.SGD","IE00BHPRN162.USD","LU0158827781.USD","LU0642271901.SGD","LU1721428933.USD","LU2361045086.USD","LU0390134368.USD","LU2417539215.USD","BK4503","LU1066051225.USD","LU0672654240.SGD","BK4533","LU1496350502.SGD","LU2168564495.EUR","LU2023251221.USD","LU0494093205.USD","LU0198837287.USD","LU2265009873.SGD","BK4516","LU0345770993.USD","LU0823434583.USD","BK4554","LU1037948541.HKD","LU1629891620.HKD","LU0274383776.USD","LU2433249047.HKD","SG9999015945.SGD","LU0820562030.AUD","IE00BJJMRY28.SGD","LU0234570918.USD","LU1084165304.USD","LU0965509010.AUD","LU0107464264.USD","LU1242518931.SGD","LU0345768153.USD","SG9999014898.SGD","IE00BZ1G4Q59.USD","LU2237957811.SGD","BK4548","LU0456854461.SGD","BK4511","LU0323591593.USD","NVDD","IE00BDRTCR15.USD","LU0861579265.USD","LU0061474705.USD","SGXZ99366536.SGD","LU2322448957.HKD","IE00BYXW3230.USD","LU0557290698.USD","LU2237957902.USD","LU0266512473.USD","BK4592","LU0345781412.USD","IE00B1XK9C88.USD","LU2471134796.USD","IE0034235303.USD","BK4587","LU0985320562.USD","LU0175139822.USD","LU2097344431.USD","IE00BD6J9T35.USD","SG9999014906.USD","LU1989764664.SGD","LU2471134952.CNY","LU0256863902.USD","LU0072462426.USD","LU0417517546.SGD","LU1366333091.USD","LU2054465674.USD","LU0234572021.USD","LU0330918003.SGD","IE00BYQQ9H92.USD","LU1914381329.SGD","LU2065171402.SGD","LU2271345857.HKD","SG9999015952.SGD","LU2552382132.HKD","LU0096362180.USD","LU2065171311.SGD","LU2244417387.USD","BK4579","LU1861559042.SGD","LU0210533765.USD","LU0640476718.USD","LU0788109477.HKD","LU0345769128.USD","LU2361044949.HKD","LU1244550221.USD","LU0353189680.USD","LU0215105999.USD","LU0316494557.USD","LU1232071149.USD","BK4529","LU2089985449.USD","IE00BZ199S13.USD","LU1852331112.SGD","LU2272731865.HKD","LU0211328371.USD","TRUMP.USD.CC","LU0466842654.USD","LU2077746001.SGD","LU2065170008.USD","LU1066051498.USD","LU2491050071.SGD","LU2089284900.SGD","IE00BJLML261.HKD","IE00BKDWB100.SGD","IE00BJJMRX11.SGD","LU0278409577.USD","SG9999002232.USD","LU2065169927.USD","LU1303367103.USD","LU2361044865.SGD","LU0683600562.USD","LU0154236417.USD","GB00BDT5M118.USD","SGXZ51526630.SGD","LU2430703178.SGD","LU2028103732.USD","TSYW.SI","SG9999018857.SGD","IE0004445239.USD","LU2097344357.USD","SNVD.UK","NEM","LU1674673691.USD","IE0034235295.USD","LU0124676726.USD","LU0345768740.USD","BK4604","LU2168564149.EUR","BK4210","LU1951200564.SGD","LU0265550946.USD","LU2294711713.HKD","LU2552382058.USD","LU2286300806.USD","LU1316542783.SGD","LU1791710400.SGD","LU2023250504.SGD","IE00B1BXHZ80.USD","LU0868494617.USD","IE00BQXX3F31.USD","SGXZ31699556.SGD","LU0056508442.USD","BK4146","LU0276348264.USD","LU1035775433.USD","LU1145028129.USD","LU0788109121.HKD","LU2505996509.AUD","LU0251132253.USD","LU1934455863.HKD","LU0203201768.USD","LU2111349929.HKD","LU2083900584.USD","NVD2.UK","LU0868494708.USD","LU0889565833.HKD","SG9999014567.USD","LU0238689110.USD","LU0157215616.USD","LU2236285917.USD","BK4567","LU0476273544.USD","SG9999017495.SGD","LU1923623000.USD","LU0310799852.SGD","BK4588","LU0957808578.USD","LU1429558221.USD","IE0005OL40V9.USD","LU1116320901.HKD","LU1935042991.SGD","IE00B3M56506.USD","LU0075056555.USD","LU1496350171.SGD","LU1868837300.USD","LU0061474960.USD","IE00BDCRKT87.USD","LU2491049909.HKD","IE00BFSS8Q28.SGD","LU2063271972.USD","LU0823414478.USD","LU0055631609.USD","SG9999018865.SGD","LU1861215975.USD","BK4532","LU0889566641.SGD","LU0498741890.SGD","LU2471134879.HKD","NVDY","LU2213496289.HKD","LU1935042215.USD","BK4608","IE00BMPRXN33.USD","LU0300736492.USD","LU1267930490.SGD","CORT","IE00B19Z8X17.USD","LU1261432733.SGD","IE00BQXX3C00.GBP","LU0823414551.USD"],"gpt_icon":1},{"id":"2595774601","title":"BUZZ-Corcept drops after US FDA declines to approve drug for rare hormonal disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2595774601","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595774601?lang=en_us&edition=fundamental","pubTime":"2025-12-31 21:30","pubTimestamp":1767187800,"startTime":"0","endTime":"0","summary":"BUZZ-Corcept drops after US FDA declines to approve drug for rare hormonal disorder** Shares of drugmaker Corcept Therapeutics CORT.O fall 38.7% to $48.39 premarket** CORT says U.S. FDA has declined to approve its hormone-blocking oral therapy, relacorilant, for the treatment of a rare hormonal disorder** FDA says \"it could not arrive at a favorable benefit-risk assessment for relacorilant without Corcept providing additional evidence of effectiveness\" - CORT** Co was testing relacorilant to treat Cushing's syndrome, also known as hypercortisolism, which occurs when the body is exposed to high cortisol activity** As of last close, stock up 39.3% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b9e90ab36df29de2b226d0a3b3c0d142","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nL4N3Y10II:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4007","CORT","LU0566484027.USD","LU1559883803.SGD"],"gpt_icon":0},{"id":"2595542774","title":"Corcept Therapeutics' Relacorilant Faces Setback as FDA Issues Complete Response Letter on Hypertension Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2595542774","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595542774?lang=en_us&edition=fundamental","pubTime":"2025-12-31 21:27","pubTimestamp":1767187648,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics (CORT) said Wednesday that the Food and Drug Administration (FDA) issued a Complete Response Letter for its New Drug Application seeking approval of relacorilant to treat hyperten","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0566484027.USD","LU1559883803.SGD","BK4532","BK4007","CORT"],"gpt_icon":0},{"id":"2595743007","title":"Shares of Corcept Therapeutics Fall 34.5% Premarket After US FDA Declines to Approve Co's Drug for Rare Hormonal Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2595743007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595743007?lang=en_us&edition=fundamental","pubTime":"2025-12-31 21:23","pubTimestamp":1767187434,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"9a0c1cf4b863b8a2bc2810d88152fbf3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nFWN3Y108J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4532","LU1559883803.SGD","CORT","LU0566484027.USD"],"gpt_icon":0},{"id":"2595771281","title":"BRIEF-Corcept Receives Complete Response Letter For Relacorilant As A Treatment For Patients With Hypercortisolism","url":"https://stock-news.laohu8.com/highlight/detail?id=2595771281","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595771281?lang=en_us&edition=fundamental","pubTime":"2025-12-31 21:06","pubTimestamp":1767186365,"startTime":"0","endTime":"0","summary":"BRIEF-Corcept Receives Complete Response Letter For Relacorilant As A Treatment For Patients With HypercortisolismDec 31 (Reuters) - Corcept Therapeutics Inc CORT.O:CORCEPT RECEIVES COMPLETE RESPONSE ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nTUA6DTLZX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT","BK4532","LU1559883803.SGD","LU0566484027.USD","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corcept.com","stockEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":-0.5869},{"period":"3month","weight":-0.5268},{"period":"6month","weight":-0.5027},{"period":"1year","weight":-0.2881},{"period":"ytd","weight":0.0445}],"compareEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.1933},{"period":"ytd","weight":0.0174}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Corcept Therapeutics Incorporated engages in discovery and development of drugs for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. It offers Korlym tablets medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous cushing's syndrome; and who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also developing relacorilant, which is in phase III clinical trial for the treatment of cushing's syndrome; treatment for adrenal cancer and cortisol excess which is in phase 1b clinical trial; treatment for prostate cancer which is in phase II clinical trial; and nab-paclitaxel in combination with relacorilant, which is in phase III clinical trial to treat platinum-resistant ovarian tumors. In addition, it develops dazucorilant, which is in phase II clinical trial for the treatment of amyotrophic lateral sclerosis; miricorilant, which is in phase IIb trial for the treatment of nonalcoholic steatohepatitis; and treatment for antipsychotic induced weight gain that is in phase I trial. The company was incorporated in 1998 and is headquartered in Menlo Park, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.01774},{"month":2,"riseRate":0.428571,"avgChangeRate":0.014054},{"month":3,"riseRate":0.761905,"avgChangeRate":0.141286},{"month":4,"riseRate":0.52381,"avgChangeRate":-0.001402},{"month":5,"riseRate":0.5,"avgChangeRate":0.00703},{"month":6,"riseRate":0.454545,"avgChangeRate":0.039099},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.006529},{"month":8,"riseRate":0.409091,"avgChangeRate":-0.006283},{"month":9,"riseRate":0.454545,"avgChangeRate":0.062175},{"month":10,"riseRate":0.5,"avgChangeRate":-0.005789},{"month":11,"riseRate":0.5,"avgChangeRate":0.018834},{"month":12,"riseRate":0.409091,"avgChangeRate":0.027449}],"exchange":"NASDAQ","name":"Corcept Therapeutics","nameEN":"Corcept Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corcept Therapeutics(CORT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Corcept Therapeutics(CORT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Corcept Therapeutics,CORT,Corcept Therapeutics股票,Corcept Therapeutics股票老虎,Corcept Therapeutics股票老虎国际,Corcept Therapeutics行情,Corcept Therapeutics股票行情,Corcept Therapeutics股价,Corcept Therapeutics股市,Corcept Therapeutics股票价格,Corcept Therapeutics股票交易,Corcept Therapeutics股票购买,Corcept Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corcept Therapeutics(CORT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Corcept Therapeutics(CORT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction